Overview Once Weekly Infant Corticosteroid Trial for DMD Status: Recruiting Trial end date: 2024-12-30 Target enrollment: Participant gender: Summary The hypothesis tested here is that a lower dose of intermittent oral corticosteroids (5mg/kg/week) will be equally effective to the 10mg/kg/week dose. Phase: Phase 4 Details Lead Sponsor: Anne M. ConnollyCollaborators: Ann & Robert H Lurie Children's Hospital of ChicagoChildren's Hospital Medical Center, CincinnatiTreatments: Prednisolone